HPV

Vaccines for HPV

By Unknown - May 31, 2018


Vaccines for HPV
HEALTH MATTERS
Understanding HPV Vaccines Health Matters is a publication of ARHP for the general public that provides a brief overview of existing facts and data on various topics related to reproductive health.



Most people who have sex will get HPV sometime in their lives; however, few people will realize they have HPV. In fact, most HPV infections go away naturally in less than two years.
There is no treatment for an HPV infection. HPV that does not go away on its own can cause abnormal cells that may lead to cancer of the cervix. HPV also causes many anal cancers, as well as some cancers of the vagina, vulva, penis, head, and neck.

There are more than 100 different types of HPV. Some types can cause genital warts, and about 15 types can cause HPV-related cancers.
HPV types that cause genital warts are referred to as “low-risk.” HPV 6 and 11 are two low-risk types that are responsible for about 90% of genital warts.
HPV types that cause certain cancers are referred to as “high-risk.” Two high-risk types, HPV 16 and 18, cause about 70% of all cervical cancers. Other high-risk
HPV types cause the other 30%.

HPV vaccines can prevent infection by some of the most common types of HPV. Vaccines may reduce the risk of cervical, vulvar, vaginal and anal cancers and pre-cancers, as well as genital warts. There are two vaccines available:

1. Gardasil, approved in 2006 for use in females ages 9 through 26, protects against four types of HPV – two high-risk types (HPV types 16 and 18) and two low-risk types (HPV types 6 and 11). In 2009, Gardasil was approved for use in males ages through 26. Gardasil is used to prevent cervical, vulvar, vaginal and anal cancers and pre-cancers caused by HPV 16 and 18, as well as genital warts caused by HPV 6 and 11.
 
2. Cervarix, approved in 2009 for use in females ages 10 through 25, protects against two high-risk types of HPV, 16 and 18. Cervarix is used to prevent cervical cancer and pre-cancer caused by HPV 16 and 18. In 2011, the approval for Cervarix was extended to girls as young as age 9.

Sourced from: www.arhp.org/healthmatters  

 

  • Share:

You Might Also Like

0 comments